VANGUARD GROUP INC - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 18 filers reported holding TRANSCODE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$220,000
-12.7%
200,1170.0%0.00%
Q2 2022$252,000
-56.2%
200,1170.0%0.00%
Q1 2022$576,000
+13.4%
200,1170.0%0.00%
Q4 2021$508,000
-15.1%
200,1170.0%0.00%
Q3 2021$598,000200,1170.00%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
One68 Global Capital, LLC 30,120$10,1960.02%
SHEETS SMITH WEALTH MANAGEMENT 60,000$20,3100.00%
Warberg Asset Management LLC 20,000$6,7700.00%
Shay Capital LLC 15,060$5,0980.00%
WELLS FARGO & COMPANY/MN 51$170.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 75,683$25,6410.00%
STATE STREET CORP 21,019$7,1210.00%
GOLDMAN SACHS GROUP INC 13,122$4,4420.00%
BlackRock Inc. 1,385$4690.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders